華潤三九(000999.SZ):2024年淨利潤同比增長18.05% 擬10股轉3股派3.2元
格隆匯3月12日丨華潤三九(000999.SZ)公佈2024年年度報告,2024年,公司實現營業收入276.17億元,較上年同期增長11.63%;公司實現經營活動產生的現金流量淨額44.02億元,較上年同期同比增長5.02%;實現歸屬於上市公司股東的淨利潤33.68億元,較上年同期增長18.05%;實現歸屬於上市公司股東的扣除非經常性損益的淨利潤31.18億元,同比增長15.01%。向全體股東每10股派發現金紅利3.2元,以資本公積金向全體股東每10股轉增3股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.